Stay updated on Finerenone in HF with LVEF ≥40% Clinical Trial
Sign up to get notified when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.

Latest updates to the Finerenone in HF with LVEF ≥40% Clinical Trial page
- Check2 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA 403 Forbidden error page is now displayed for the study record, showing a 403 message and a Home button. This indicates access to the study content is blocked rather than the study details being shown.SummaryDifference16%

- Check23 days agoChange DetectedRevision: v3.7.0 was added to indicate an updated page version. A citation related to Finerenone QoL and the older revision tag v3.6.6 were removed.SummaryDifference0.0%

- Check37 days agoChange DetectedThree new publications citing the study citing the trial have been added to Publications: a JACC Heart Fail paper on HFpEF-ABA scores in FINEARTS-HF, a J Am Coll Cardiol paper on low-normal hemoglobin in heart failure, and a Eur J Heart Fail analysis on time-in-range blood pressure in HFmrEF/HFpEF. These entries broaden the scholarly context around the trial.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page shows a revision bump to v3.6.6, replacing the previous v3.6.5. This indicates a small platform update with no substantive changes to the study information.SummaryDifference0.0%

- Check80 days agoChange DetectedA new citation by Hamatani et al. on KCCQ-12 and KCCQ-23 across >18,000 participants is added to the Publications section, and the March 2026 online-ahead-of-print citation is removed; the study record version is updated from v3.6.3 to v3.6.4.SummaryDifference0.0%

Stay in the know with updates to Finerenone in HF with LVEF ≥40% Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.